Relay Therapeutics, Inc.
RLAY
$3.69
$0.288.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -311.55M | -333.39M | -337.71M | -345.20M | -322.83M |
| Total Depreciation and Amortization | 4.91M | 5.28M | 5.46M | 5.51M | 5.50M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 68.41M | 64.55M | 68.52M | 66.70M | 65.15M |
| Change in Net Operating Assets | -23.19M | -8.44M | 14.62M | -7.43M | -28.56M |
| Cash from Operations | -261.42M | -271.99M | -249.11M | -280.43M | -280.74M |
| Capital Expenditure | -637.00K | -622.00K | -2.02M | -2.14M | -2.50M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.08M | -8.53M | -39.07M | -8.27M | 189.62M |
| Cash from Investing | 20.45M | -9.15M | -41.08M | -10.40M | 187.12M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 220.34M | 221.23M | 270.15M | 291.27M | 81.84M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 220.34M | 221.23M | 270.15M | 291.27M | 81.84M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.63M | -59.91M | -20.04M | 441.00K | -11.78M |